Literature DB >> 18212060

Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor.

Suxia Bai1, Elizabeth M Wilson.   

Abstract

The androgen receptor (AR) is a ligand-activated transcription factor that interacts with coregulatory proteins during androgen-dependent gene regulation. Melanoma antigen gene protein 11 (MAGE-11) is an AR coregulator that specifically binds the AR NH(2)-terminal FXXLF motif and modulates the AR NH(2)- and carboxyl-terminal N/C interaction to increase AR transcriptional activity. Here we demonstrate that epidermal growth factor (EGF) signaling increases androgen-dependent AR transcriptional activity through the posttranslational modification of MAGE-11. EGF in the presence of dihydrotestosterone stabilizes the AR-MAGE complex through the site-specific phosphorylation of MAGE-11 at Thr-360 and ubiquitinylation at Lys-240 and Lys-245. The time-dependent EGF-induced increase in AR transcriptional activity by MAGE-11 is mediated through AR activation functions 1 and 2 in association with the increased turnover of AR and MAGE-11. The results reveal a dynamic mechanism whereby growth factor signaling increases AR transcriptional activity through the covalent modification of an AR-specific coregulatory protein. Sequence conservation of the MAGE-11 phosphorylation and ubiquitinylation sites throughout the MAGE gene family suggests common regulatory mechanisms for this group of cancer-testis antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212060      PMCID: PMC2268407          DOI: 10.1128/MCB.01672-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain.

Authors:  B He; J A Kemppainen; J J Voegel; H Gronemeyer; E M Wilson
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

2.  Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2.

Authors:  B He; N T Bowen; J T Minges; E M Wilson
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

3.  Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity.

Authors:  G N Lopez; C W Turck; F Schaufele; M R Stallcup; P J Kushner
Journal:  J Biol Chem       Date:  2001-04-11       Impact factor: 5.157

4.  Mutation of the androgen receptor causes oncogenic transformation of the prostate.

Authors:  Guangzhou Han; Grant Buchanan; Michael Ittmann; Jonathan M Harris; Xiaoqing Yu; Francesco J Demayo; Wayne Tilley; Norman M Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

5.  Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.

Authors:  J Thompson; F Saatcioglu; O A Jänne; J J Palvimo
Journal:  Mol Endocrinol       Date:  2001-06

6.  An overview of the MAGE gene family with the identification of all human members of the family.

Authors:  P Chomez; O De Backer; M Bertrand; E De Plaen; T Boon; S Lucas
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

7.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels.

Authors:  L Sheflin; B Keegan; W Zhang; S W Spaulding
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

9.  A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

Authors:  C W Gregory; B He; R T Johnson; O H Ford; J L Mohler; F S French; E M Wilson
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

10.  Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation.

Authors:  Suxia Bai; Gail Grossman; Lingwen Yuan; Bruce A Lessey; Frank S French; Steven L Young; Elizabeth M Wilson
Journal:  Mol Hum Reprod       Date:  2007-11-29       Impact factor: 4.025

View more
  37 in total

1.  Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.

Authors:  William H Lagarde; Amanda J Blackwelder; John T Minges; Andrew T Hnat; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

2.  Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.

Authors:  Adam R Karpf; Suxia Bai; Smitha R James; James L Mohler; Elizabeth M Wilson
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

3.  Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.

Authors:  Qiang Liu; Shifeng Su; Amanda J Blackwelder; John T Minges; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.

Authors:  Emily B Askew; Suxia Bai; Amanda J Blackwelder; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

5.  Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.

Authors:  Leticia Y Peche; María F Ladelfa; María F Toledo; Miguel Mano; Julieta E Laiseca; Claudio Schneider; Martín Monte
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

6.  Evolution of Melanoma Antigen-A11 (MAGEA11) During Primate Phylogeny.

Authors:  Christopher S Willett; Elizabeth M Wilson
Journal:  J Mol Evol       Date:  2018-03-24       Impact factor: 2.395

Review 7.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

8.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 9.  The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer.

Authors:  Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-08-05       Impact factor: 5.678

10.  Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.

Authors:  John T Minges; Gail Grossman; Ping Zhang; Tal Kafri; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.